Diastolic dysfunction: Insights into pathophysiology and pharmacotherapy

Expert Opinion on Pharmacotherapy

Volumn 2, Issue 6, 2001, Pages 997-1008

  Maniu, C V ^a   Redfield, M M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Congestive heart failure; Diastole

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDRALAZINE; ISOSORBIDE DINITRATE; LOSARTAN; NITRATE; PLACEBO; PROPRANOLOL; VERAPAMIL;

ADULT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLE; DRUG TARGETING; DRUG THERAPY; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE RELAXATION; HUMAN; MALE; META ANALYSIS; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTOLE;

ANIMALS; CLINICAL TRIALS; CORONARY DISEASE; DIASTOLE; GUIDELINES; HEART FAILURE, CONGESTIVE; HUMANS; STROKE VOLUME; VENTRICULAR DYSFUNCTION;

EID: 0034864670     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2.6.997     Document Type: Review

References (85)

1. Echocardiographic Doppler evaluation of left ventricular diastolic function. Physics and Physiology
2. Interaction of left ventricular relaxation and filling during early diastole in human subjects
3. Left ventricular filling dynamics: Influence of left ventricular relazation and left atrial pressure
4. Relation of transmitral flow velocity patterns to left ventricular diastolic function: New insights from a combined hemodynamic and Doppler echocardiographic study
5. Passive properties of canine left ventricle: Diastolic stiffness and restoring forces
6. Pressure-volume relation around zero transmural pressure in excised cross-circulated dog left ventricle
7. The effect of acute alterations in left ventricular afterload and beta-adrenergic tone on indices of early diastolic filling rate
8. Physical and physiological determinants of transmitral velocity: Numerical analysis
9. Doppler echocardiographic assessment of the effect of varying atrioventricular delay and pacemaker mode on left ventricular filling
10. The importance of atrioventricular delay fallback in optimizing cardiac output during physiologic pacing
11. Determinants of atrial contractile force in the intact heart
12. Pressure-flow studies in man: Effect of atrial systole on left ventricular function
13. The influence of left ventricular filling pressure on atrial contribution to cardiac output
14. The influence of heart rate on Doppler mitral inflow patterns
15. Assessment of diastolic function of the heart: Background and current applications of Doppler echocardiography. Part II. Clinical studies
16. Nonivasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: A simultaneous Doppler echocardiographic and cardiac catheterization study
17. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography in the clinician's Rosetta stone
18. Analysis of left ventricular diastolic function
19. Assessment of left ventricular end-diastolic pressure by Doppler echocardiography: Contribution of duration of pulmonary venous versus mitral flow velocity curves at atrial contraction
20. Determination of left ventricular filling pressure by Doppler echocardiography in patients with coronary artery diseases: The critical role of left ventricular systolic function
21. Diastolic compliance of hypertrophied ventricle is not acutely altered by pharmacologic agents influencing active processes
22. Diastolic function and dysfunction
23. Triple control of relaxation: Implications in cardiac disease
24. Effect of heart failure on the mechanism of exercise-induced augmentation of mitral valve flow
25. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure
26. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: Failure of the Frank-Starling mechanism
27. Influence of left ventricular hypertrophy on left ventricular function during dynamic exercise in the presence or absence of coronary artery disease
28. The heart as a suction pump
29. Hemodynamic and ventricular volume correlates of peak transmitral flow velocity
30. Marked discordance between dynamic and passive diastolic pressure-volume relations in idiopathic hypertrophic cardiomyopathy
31. Left ventricular systolic and diastolic function in the huypertrophied ventricle
32. Comparative effects of ischemia and hypoxemia on left ventricular systolic and diastolic function in man
33. Normalization of diastolic dysfunction in aortic stenosis late after valve replacement
34. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study
35. Contribution of external forces to left ventricular diastolic pressure
36. The natural history of left ventricular filling abnormalities: Assessment by two-dimensional and Doppler echocardiography
37. Mechanisms of altered patterns of left ventricular filling during the development of congestive heart failure
38. Doppler characterization of left ventricular diastolic function in cardiac amyloidois
39. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure
40. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
41. Isolated diastolic dysfunction in the community
42. Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective
43. Congestive heart failure in the community: A study of all incident cases in Olmsted County, Minnesota, in 1991
44. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction
45. Heart failure with preserved LV function in the elderly: Clinical and echocardiographic correlates from the cardiovascular health study
46. How to diagnose diastolic heart failure
47. Defining diastolic heart failure. A call for standardized diagnostic criteria
48. Diastolic heart failure in the community: Underlying cardiovascular diseases and precipitating factors
49. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons
50. Impaired lusitropy-frequency in the aging mouse: Role of Ca(2+)-handling proteins and effects of isoproterenol
51. Effects of aging on left ventricular relaxation in humans
52. Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum
53. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium
54. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy
55. Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure
56. Crossbridge dynamics in human ventricular myocardium. Regulation of contractility in the failing heart
57. Differential effect of DPI 201-106 on the sensitivity of the myofilaments to Ca2+ in intact and skinned trabeculae from control and myopathic human hearts
58. The failing human heart is unable to use the Frank-Starling mechanism
59. Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: Role of altered beta-adrenergically mediated protein phosphorylation
60. Role of the contractile proteins and sarcoplasmic reticulum in the response of the heart to catecholamines: A historical review
61. The calcium and magnesium binding sites on cardiac troponin and their role in the regulation of myofibrillar adenosine triphosphatase
62. Reduced beta 1 receptor messenger RNA abundance in the failing human heart
63. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure
64. Changes in myofibrillar content and Mg-ATPase activity in ventricular tissues from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency
65. Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts
66. Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart
67. Effect of diuretic therapy on hypertensive left ventricular hypertrophy
68. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: Comparison of six antihypertensive agents
69. Guidelines for the evaluation and management of heart failure
70. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure
71. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance
72. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise
73. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction
74. Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status
75. The effect of digoxin on mortality and morbidity in patients with heart failure
76. Heart failure with normal ejection fraction. The V-HeFT Study
77. Systolic versus diastolic heart failure in community practice: Clinical features and outcomes in 1,694 patients
78. Factors influencing survival in patients with diastolic heart failure in Olmsted County, MN in 1996-97
79. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies
80. Failure of calcium channel blockers to improve ventricular relaxation in humans
81. Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy
82. Intracoronary angiotensin-converting enzyme inhibition improves diastolic function in patients with hypertensive left ventricular hypertrophy
83. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis
84. 8-bromocGMP reduces the myofilament response to CA2+ in intact cardiac myocyte
85. Effect of the endogenous natriuretic peptide system on ventricular and coronary function in the failing canine heart